Dow Inc.: Q1 Earnings Snapshot

By The Associated Press
April 23, 2026 | 6:10 AM

MIDLAND, Mich. (AP) — MIDLAND, Mich. (AP) — Dow Inc. (DOW) on Thursday reported a loss of $533 million in its first quarter.

The Midland, Michigan-based company said it had a loss of 74 cents per share. Losses, adjusted for non-recurring costs, came to 14 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.

The materials science posted revenue of $9.79 billion in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $9.5 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DOW at https://www.zacks.com/ap/DOW

FDA fills four senior roles, including top officials for drugs, vaccines and tobacco

By The Associated Press
September 8, 2026 | 6:10 PM

WASHINGTON (AP) — The administration of President Donald Trump filled four senior positions at the Food and Drug Administration on Tuesday, promoting several officials who had been serving in acting roles to permanently fill the spots, including the agency’s top leaders for drugs and vaccines. The announcement by the Department of Health and Human Services, which oversees the FDA, gives the agency some stability following months of controversy and upheaval that led to a series of high-profile departures earlier this year. The announcement names permanent directors for three of the agency’s six centers: drugs, vaccines and biologics and tobacco products. All three areas have seen major policy shifts under the Trump administration and attracted scrutiny from consumer groups, physicians and Democrats in Congress. Dr. Michael Davis was named to lead the agency’s Center for Drug Evaluation and Research, the agency’s largest center responsible for the safety and effectiveness of prescription and over-the-counter drugs. He'd been serving in an acting role since the departure of Dr. Tracy Beth Hoeg, who said she was fired from the job in May. Hoeg’s brief time at the agency mainly focused on scrutinizing antidepressants, COVID shots and other drugs used in children.

Related Stories